Table 2.
Patients and histopathological tumor characteristics of rectal adenocarcinomas which underwent laser capture microdissection and proteome analysis by isotope coded protein label (ICPL); nCRT I: 50.4 Gy + 5-FU; nCRT II: 50.4 Gy + 5-FU/Oxaliplatin.
| Patients | nCRT I | nCRT II |
|---|---|---|
| n | 10 | 10 |
| Male | 9 | 7 |
| Female | 2 | 3 |
| ypT-category | ||
| yT0 | 1 | 3 |
| yT1 | 0 | 0 |
| yT2 | 3 | 1 |
| yT3 | 5 | 6 |
| yT4 | 1 | 0 |
| ypN-category | ||
| yN0 | 4 | 7 |
| yN1 | 5 | 3 |
| yN2 | 1 | 0 |
| Distant metastasis | ||
| M0 | 9 | 9 |
| M1 | 1 | 1 |
| Grading | ||
| G1/2 | 6 | 6 |
| G3/4 | 3 | 2 |
| GX | 1 | 2 |
| Regression Grading (Dworak) | ||
| Dworak 1 | 2 | 0 |
| Dworak 2 | 3 | 5 |
| Dworak 3 | 4 | 2 |
| Dworak 4 | 1 | 3 |